Biography and Research Information
OverviewAI-generated summary
Hannah Wu's research investigates the in vitro antibacterial activity of nimbolide against Helicobacter pylori, as detailed in her 2021 publication. She also contributed to research on novel compound heterozygous mutations in ILNEB Syndrome, published in 2025. Wu's scholarly work includes 2 publications with a total of 26 citations and an h-index of 1. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Jay Kincannon, Khiem A. Tran, Joshua Hekmatjah, and Mack B. Stokes, each sharing one publication with Wu. Her recent activity indicates ongoing engagement in research.
Metrics
- h-index: 1
- Publications: 2
- Citations: 26
Selected Publications
-
Novel Compound Heterozygous Mutations in ILNEB Syndrome (2025)
Collaboration Network
Top Collaborators
- In vitro antibacterial activity of nimbolide against Helicobacter pylori
- In vitro antibacterial activity of nimbolide against Helicobacter pylori
- In vitro antibacterial activity of nimbolide against Helicobacter pylori
- In vitro antibacterial activity of nimbolide against Helicobacter pylori
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
Similar Researchers
Based on overlapping research topics